1. Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha‐2b in metastatic melanoma (phase II DeCOG trial). (23rd July 2013) Authors: Degen, Annette; Weichenthal, Michael; Ugurel, Selma; Trefzer, Uwe; Kilian, Katharina; Garbe, Claus; Egberts, Friederike; Poppe, Lìdia Marilia; Hauschild, Axel; Gutzmer, Ralf Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 11:Number 9(2013) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Kutane Nebenwirkungen der Kombinationstherapie mit Sorafenib und pegyliertem Interferon alfa‐2b bei metastasiertem Melanom (ADO SoraPeg‐Studie). (19th August 2013) Authors: Degen, Annette; Weichenthal, Michael; Ugurel, Selma; Trefzer, Uwe; Kilian, Katharina; Garbe, Claus; Egberts, Friederike; Poppe, Lìdia Marilia; Hauschild, Axel; Gutzmer, Ralf Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 11:Number 9(2013) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗